Blood News and Research

RSS

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jan 2010

Talampanel slows progression of amyotrophic lateral sclerosis

A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial-an early, small-scale test to show if the drug works and continues to be safe.

5 Jan 2010

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

In patients with chronic hepatitis C, treatment with peginterferon alpha-2a (PegIFNα2a) plus ribavirin (RBV) better suppresses the virus to undetectable levels in the blood than treatment with peginterferon alpha-2b (PegIFNα2b) plus RBV, according to two new head-to-head studies in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

5 Jan 2010

Elusys Therapeutics signs contract to complete the final development of Anthim

Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company, announced today that it has signed a contract potentially totaling up to $143 million to complete the final development, commercial manufacturing and licensure of Anthim, the company's late stage anthrax therapeutic.

5 Jan 2010

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

5 Jan 2010

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

5 Jan 2010

Cord Blood America signs Letter of Intent to process and store cord blood specimens for BioCells

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.

4 Jan 2010

Pfizer's Revatio solution for injection receives European Commission approval

Pfizer Inc. announced today that the European Commission has approved Revatio® (sildenafil) solution for injection for patients who are currently prescribed oral Revatio and who are temporarily unable to take oral medicine, but are otherwise clinically and haemodynamically stable.

4 Jan 2010

Sunlighten to unveil mPulse Series in April 2010

Sunlighten(TM) (www.sunlighten.com) is proud to unveil its mPulse(TM) Series, set to launch in April 2010, which is the world's first sauna with personalized biofeedback tracking as well as customizable full spectrum infrared heat that targets specific health concerns.

4 Jan 2010

Virtual Education and Simulation Training Center serves as virtual hospital

At Christiana Care Health System's VEST Center, babies are born every day, just as they are in a real hospital. Adults and children are rushed to the emergency department with injuries suffered in accidents. Patients are intubated, have their blood drawn and get IV drips.

4 Jan 2010

Experimental lung cancer drug promising against brain cancer glioblastoma and prostate cancer

An experimental drug currently being tested against breast and lung cancer shows promise in fighting the brain cancer glioblastoma and prostate cancer, researchers at UT Southwestern Medical Center have found in two preclinical studies.

4 Jan 2010

Novelos continues NOV-002 Phase 3 combination trial for lung cancer

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.

4 Jan 2010

Study shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism

A 5-year study of patients with severe traumatic brain injury conducted at Hennepin County Medical Center in Minneapolis shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism and its ability to recover from injury.

4 Jan 2010

D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke

D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).

3 Jan 2010

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells.

31 Dec 2009

NYC physical therapist encourages women to incorporate physical activity to manage stress levels

Life is full of hassles, deadlines, frustrations and demands. Stress can take its toll on a woman’s health and spill into the home during the holiday season. In these economic times, tightening budgets during the ‘season to be jolly’ brings additional stress.

31 Dec 2009

Rh-negative blood supply prioritized as tri-state area braces for winter months

New York Blood Center (NYBC) serving New York City, Long Island, Hudson Valley and New Jersey calls upon the community to please donate blood today. Blood drive cancellations from the weekend storm of December 19, 2009, coupled with unusually high demand from regional hospitals, have impacted Rh-negative blood supplies, especially type O-negative.

31 Dec 2009

UT Southwestern doctor uses a viable alternative in aortic graft surgery

A vascular surgical technique pioneered at UT Southwestern Medical Center and designed to replace infected aortic grafts with the body's own veins has proved more durable and less prone to new infection than similar procedures using synthetic and cadaver grafts.

31 Dec 2009

OmSanA: A natural dietary supplement for maintaining blood sugar and cholesterol levels

As the nation prepares to watch the ball drop in Times Square, Americans will reminisce about the past year and make resolutions for 2010—many will be focused on getting and remaining healthy—and just being normal. Yes, that’s right…normal.

31 Dec 2009

Cardiologist wins stimulus grant to identify biomarkers of idiopathic pulmonary hypertension

Johns Hopkins Children's Center cardiologist Allen Everett recently won more than $460,000 in stimulus grant funding to identify the biomarkers of idiopathic pulmonary hypertension (IPH), a progressive and highly lethal condition in children and adults marked by persistently elevated pressure in the artery that carries blood from the heart to the lungs.

31 Dec 2009

Blood News and Research

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Talampanel slows progression of amyotrophic lateral sclerosis

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

Elusys Therapeutics signs contract to complete the final development of Anthim

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

A 'cocktail' to kill cancerous tumors

Cord Blood America signs Letter of Intent to process and store cord blood specimens for BioCells

Pfizer's Revatio solution for injection receives European Commission approval

Sunlighten to unveil mPulse Series in April 2010

Virtual Education and Simulation Training Center serves as virtual hospital

Experimental lung cancer drug promising against brain cancer glioblastoma and prostate cancer

Novelos continues NOV-002 Phase 3 combination trial for lung cancer

Study shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism

D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

NYC physical therapist encourages women to incorporate physical activity to manage stress levels

Rh-negative blood supply prioritized as tri-state area braces for winter months

UT Southwestern doctor uses a viable alternative in aortic graft surgery

OmSanA: A natural dietary supplement for maintaining blood sugar and cholesterol levels

Cardiologist wins stimulus grant to identify biomarkers of idiopathic pulmonary hypertension

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News